Home » Merck Seeks Ridaforolimus Marketing Approval From EMA
Merck Seeks Ridaforolimus Marketing Approval From EMA
Merck has filed a marketing authorization application (MAA) for ridaforolimus with the European Medicines Agency (EMA).
PBR
PBR
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May